| Role |
Name |
Disclosure |
Details |
| Author | Robert A Schwartz, MD, MPH, Professor and Head of Dermatology, Professor of Medicine, Professor of Pediatrics, Professor of Pathology, Professor of Preventive Medicine and Community Health, UMDNJ-New Jersey Medical School | Nothing to disclose | Details | | Coauthor | W Clark Lambert, MD, PhD, Professor and Head, Dermatopathology, Departments of Pathology and Dermatology, UMDNJ-New Jersey Medical School | Nothing to disclose | Details | | Medical Editor | Abby S Van Voorhees, MD, Assistant Professor, Director of Psoriasis Services and Phototherapy Units, Department of Dermatology, University of Pennsylvania School of Medicine, Hospital of the University of Pennsylvania | Amgen Astellas Abbott Genentech Incyte Centocor Warner Chilcott Merck | Details | | Pharmacy Editor | Michael J Wells, MD, Associate Professor, Department of Dermatology, Texas Tech University Health Sciences Center | Nothing to disclose | Details | | Managing Editor | Christen M Mowad, MD, Assistant Professor, Department of Dermatology, Geisinger Medical Center | Nothing to disclose | Details | | CME Editor | Joel M Gelfand, MD, MSCE, Medical Director, Clinical Studies Unit, Assistant Professor, Department of Dermatology, Associate Scholar, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania | AMGEN AMGEN Genentech Centocor Centocor Covance Shire | Details | | Chief Editor | Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center | Nothing to disclose | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| W Clark Lambert, Coauthor |
The contributor discloses no conflict of interest. |
|